Related references
Note: Only part of the references are listed.Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections
Maria Iris Cassetta et al.
BIOMETALS (2014)
The thioredoxin antioxidant system
Jun Lu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Importance of Bacillithiol in the Oxidative Stress Response of Staphylococcus aureus
Ana C. Posada et al.
INFECTION AND IMMUNITY (2014)
Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus
Mary E. Hensler et al.
JOURNAL OF ANTIBIOTICS (2014)
Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains
Yozane Hokai et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Alimuddin I. Zumla et al.
LANCET INFECTIOUS DISEASES (2014)
Specialized Transduction Designed for Precise High-Throughput Unmarked Deletions in Mycobacterium tuberculosis
Paras Jain et al.
MBIO (2014)
A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
Noa Tejman-Yarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Glutathione analogs in prokaryotes
Robert C. Fahey
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Tuberculosis 2013:5 Drug-resistant tuberculosis: time for visionary political leadership
Ibrahim Abubakar et al.
LANCET INFECTIOUS DISEASES (2013)
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition
Andrea Ilari et al.
AMINO ACIDS (2012)
Why do bacteria use so many enzymes to scavenge hydrogen peroxide?
Surabhi Mishra et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
The biological activity of auranofin: implications for novel treatment of diseases
J. M. Madeira et al.
INFLAMMOPHARMACOLOGY (2012)
The challenge of new drug discovery for tuberculosis
Anil Koul et al.
NATURE (2011)
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
Jennifer E. Griffin et al.
PLOS PATHOGENS (2011)
The use of thiols by ribonucleotide reductase
Arne Holmgren et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
How antibiotics kill bacteria: from targets to networks
Michael A. Kohanski et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Optimisation of Bioluminescent Reporters for Use with Mycobacteria
Nuria Andreu et al.
PLOS ONE (2010)
Biosynthesis and functions of bacillithiol, a major low-molecular-weight thiol in Bacilli
Ahmed Gaballa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin STRUCTURAL AND KINETIC ASPECTS
Francesco Angelucci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge.
Cesar A. Arias et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Functional Studies of Multiple Thioredoxins from Mycobacterium tuberculosis
Mohd Akif et al.
JOURNAL OF BACTERIOLOGY (2008)
Gold(I)-mediated inhibition of protein tyrosine phosphatases:: A detailed in vitro and cellular study
Divya Krishnamurthy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Catherine Vilcheze et al.
MOLECULAR MICROBIOLOGY (2008)
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
James C. Sacchettini et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies
Randall J. Basaraba
TUBERCULOSIS (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Thioredoxin glutathione reductase from schistosoma mansoni:: An essential parasite enzyme and a key drug target
Angela N. Kuntz et al.
PLOS MEDICINE (2007)
Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis
T Jaeger et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Transcriptional regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress
O Uziel et al.
JOURNAL OF BACTERIOLOGY (2004)
Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I)
A Chircorian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
KI Jeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2003)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
Tuberculosis: A problem with persistence
GR Stewart et al.
NATURE REVIEWS MICROBIOLOGY (2003)
Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling
JC Betts et al.
MOLECULAR MICROBIOLOGY (2002)
Roles of thiol-redox pathways in bacteria
D Ritz et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)
Share Paper
